ReviewFrontiers in pharmacology2016

Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis.

Susan Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.